|
Market Cap (24-Jun) $3,159,507 (1,963rd) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 42,322 |
Shortsold (5-Apr) 9,554 (0.01%) (569th) |
|
52w High $0.020 |
52w Low $0.005 |
P/E - |
EPS -0.01 |
ANR released this announcement to the ASX on 21 October 2020, 10:17. The announcement is marked as price sensitive, and is 4 page(s) in length and 255.66kb in size.
You can view all announcements from ANR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ANR was 0.075% short sold according to ASIC data. It was ranked the 425th most shorted stock on the ASX. It remains ranked 569th as of the latest reported data (05 April 2024).
| Other Recent Announcements from ANR | |
|---|---|
| Anatara Update on GaRP Irritable Bowel Syndrome Trial | 6 June 2023, 8:19 |
| Anatara Investor Presentation | 8 May 2023, 10:44 |
| Registered Office Change | 20 April 2023, 11:51 |
| Appendix 4C & Q3 FY23 Activities Report | 20 April 2023, 9:07 |
| Completed Placement and announced Share Purchase Plan | 21 October 2020, 10:17 |
| Trading Halt | 19 October 2020, 9:23 |
| Non-Executive Director Retirement | 19 October 2020, 8:57 |
You must be logged in to post a reply.
Anatara Lifesciences 